EuBiologics

EuBiologics is a CRMO (Contract Research and Manufacturing Organization) company that provides customized services for mammalian cell and microbial-derived biopharmaceuticals, ranging from cell development to GMP production. Our goal is to become an ideal strategic partner, offering appropriate solutions for our customers' product development and manufacturing, collaborating with globally leading companies to help customers manage projects effortlessly, saving valuable time and costs. The company’s COVID-19 candidate vaccine, EuCorVac-19, has been approved by the Ministry of Food and Drug Safety for Phase I/II clinical trials and has immediately entered Phase I clinical trials. Eucorac-19 is a safe vaccine utilizing recombinant protein technology combined with coronavirus spike proteins and includes an effective adjuvant, similar to other licensed viral vaccines worldwide. EuCorVac-19 is a liquid injectable in glass vials that can be stored and distributed under refrigerated temperatures, leveraging the universal distribution systems of biopharmaceuticals.